Trial Profile
Clinical Trials Insight: 700051217
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2010
Price :
$35
*
At a glance
- Drugs MCD 386 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Mithridion
- 19 Nov 2009 New trial record.